. 2012 Nov 3;12(11):e6132. doi: 10.5812/hepatmon.6132

Table 1. Mean ± SD of the Studied Parameters in All Groups.

	Control, (n = 10), Mean ± SD	CHC Without Cirrhosis, (n = 30), Mean ± SD	CHC With Cirrhosis, (n = 30), Mean ± SD	HCC, (n = 30), Mean ± SD
Tissue Fas, within 10 successive microscopic fields (× 400)/ section (mean percentage) + ve cells ± S.D	1.8 ± 0.8	25.0 ± 5.74 ^a	61.36 ± 4.69 ^a, ^b	27.3 ± 5.6 ^a, ^c
Tissue FasL, within 10 successive microscopic fields (× 400)/ section (mean percentage)+ ve cells ± SD	00 ± 00	33.46 ± 11.91 ^a	49.83 ± 8.20 ^a, ^b	45.32 ± 6.4 ^a, ^b
sFas, pg/ml	165.5 ± 45.6	238.27 ± 135.29 ^a	814.94 ± 362 ^a, ^b	762.18 ± 437 ^a, ^b

Abbreviations: CHC, chronic hepatitis C; HCC, hepatocellular carcinoma.

^aP Statistically significant from control group (P < 0.01).

^bP Statistically significant from CHC without cirrhosis group (P < 0.01).

^cP Statistically significant from cirrhosis group (P < 0.01).